microRNA的全球市場 - 市場規模、佔有率和成長分析：按研究工具（服務和產品）、最終用途（生物技術公司、製藥公司、學術和政府研究機構） - 產業預測（2023-2030）

Global MicroRNA Market Size, Share, Growth Analysis, By Research Tool(Service and product), By End-use(Biotechnology and pharmaceutical companies, academic and government research institutes) - Industry Forecast 2023-2030

出版日期: 2023年10月05日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年全球microRNA市場規模為100,159萬美元，2022年為117,386萬美元。預計在預測期內（2023-2030年），該市場將以17.2%的年複合成長率擴張，到2030年將成長至41.7866億美元。

近年來，在分子生物學、基因組學和生物資訊學進步的推動下，全球 microRNA 市場經歷了顯著擴張。 MicroRNA (miRNA) 是一種小型非編碼 RNA，在調節基因表現中發揮著至關重要的作用，作為多種疾病的有價值的生物標記和治療性介入的潛在標靶而引起了人們的關注。人們越來越了解 miRNA 在疾病途徑中的作用及其作為診斷和治療工具的潛力，正在推動這一市場的成長。癌症、心血管疾病和神經系統疾病等慢性疾病的盛行率不斷上升也支持了這一趨勢。 MicroRNA 在疾病診斷、預後和治療方面顯示出巨大潛力，刺激了該領域的研究工作和投資的增加。此外，次世代定序和微陣列平台等先進的miRNA分析和檢測技術的出現，簡化了miRNA生物標記的分析和鑑定，進一步推動了市場的擴張。然而，全球 microRNA 市場面臨一些必須解決的障礙，以確保持續成長。一個關鍵的挑戰在於基於 miRNA 的治療和診斷的複雜法律規範。基於 miRNA 的產品的核准過程需要嚴格的法規條件和臨床試驗，既耗時又昂貴。確保基於 miRNA 的干涉措施的安全性、有效性和特異性給研究人員和行業相關人員帶來了主要障礙。另一個障礙是我們對 miRNA 功能及其在生物系統中複雜相互作用的了解有限。

基因組學和分子生物學的快速發展，以次世代定序和微陣列平台等創新為代表，開創了高通量 microRNA 分析的時代。這些最尖端科技為研究人員提供了發現和詳細分析 microRNA 的必要設備，從而推動了研究活動並刺激了市場活性化。

癌症、心血管疾病和神經系統疾病等慢性疾病的盛行率在全球範圍內呈上升趨勢。 MicroRNA 作為早期識別和評估這些疾病的指標顯示出巨大的潛力。對精確、非侵入性診斷設備的需求不斷成長，引發了人們對 microRNA 研究和進步的興趣。

本報告檢視了全球 microRNA 市場，並提供了市場概述，包括按研究工具、最終用途、地區和參與市場的公司概況分類的趨勢。

主要企業簡介
- Qiagen
- Thermo Fisher Scientific Inc
- Agilent Technologies, Inc.
- Illumina, Inc.
- Merck KGaA
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- System Biosciences LLC
- New England Biolabs, Inc
- NanoString Technologies, Inc.
- Exiqon A/S
- Takara Bio Inc.
- GenScript Biotech Corporation
- Eurofins Scientific SE
- Novartis AG
- Bio-Techne Corporation
- Agios Pharmaceuticals, Inc.
- Abcam plc
- Promega Corporation

簡介目錄

Product Code: SQMIG35H2106

Global MicroRNA Market size was valued at USD 1001.59 Million in 2021 and is poised to grow from USD 1173.86 Million in 2022 to USD 4178.66 Million by 2030, at a CAGR of 17.2% during the forecast period (2023-2030).

In recent years, the global microRNA market has experienced notable expansion, propelled by advancements in molecular biology, genomics, and bioinformatics. MicroRNAs (miRNAs), small non-coding RNA molecules, play a pivotal role in regulating gene expression, rendering them valuable biomarkers for various diseases and potential targets for therapeutic interventions. The growing comprehension of miRNA's involvement in disease pathways and their potential as diagnostic and therapeutic tools has been a driving force behind this market growth. Additionally, the escalating prevalence of chronic diseases like cancer, cardiovascular disorders, and neurological conditions has contributed to this trend. MicroRNAs have exhibited significant promise in disease diagnosis, prognosis, and treatment, spurring heightened research efforts and investments in the field. Moreover, the emergence of advanced technologies for miRNA profiling and detection, such as next-generation sequencing and microarray platforms, has streamlined the analysis and identification of miRNA biomarkers, further propelling market expansion. Nevertheless, the global microRNA market confronts several obstacles that must be addressed to ensure sustained growth. A pivotal challenge lies in the intricate regulatory framework surrounding miRNA-based therapeutics and diagnostics. The approval process for products based on miRNAs entails rigorous regulatory prerequisites and clinical trials, which can be both time-intensive and costly. Guaranteeing the safety, effectiveness, and specificity of miRNA-based interventions presents a significant hurdle for researchers and industry stakeholders. Another obstacle pertains to the limited understanding of miRNA functions and their intricate interactions within biological systems.

Top-down and bottom-up approaches were used to estimate and validate the size of the global microRNA market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global MicroRNA Market is segmented on the basis of research tool, end-user, and region. By research tool, the market is segmented into services and products. By end use, the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutes, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Advancements in Genomics and Molecular Biology Technologies

The rapid progress in genomics and molecular biology, exemplified by innovations like next-generation sequencing and microarray platforms, has ushered in an era of high-throughput microRNA analysis. These cutting-edge technologies furnish researchers with indispensable instruments for the discovery and in-depth profiling of microRNAs, catalyzing heightened research endeavors and fueling market expansion.

Rising Prevalence of Chronic Diseases

The prevalence of chronic diseases worldwide, such as cancer, cardiovascular conditions, and neurological disorders, is on the rise. MicroRNAs have demonstrated significant promise as indicators for the early identification and assessment of these ailments. The growing requirement for precise and non-intrusive diagnostic instruments has fueled the interest in microRNA research and advancement.

Restraints:

Limited Understanding of microRNA Functions

Despite extensive research on microRNAs, many aspects of their precise functions and mechanisms of action remain elusive. The incomplete comprehension of microRNA biology presents obstacles in the identification of dependable and specific biomarkers, as well as the development of successful therapeutic interventions.

Technical and Analytical Challenges

MicroRNA research grapples with technical and analytical hurdles, encompassing precise quantification, sample variance, and the establishment of standardized analysis techniques. These impediments have the potential to undermine the consistency and trustworthiness of microRNA research findings, which, in turn, may impede market expansion.

Market Trends:

The synergy between Industry and Academia in MicroRNA Research: The convergence of biotechnology and pharmaceutical firms, academic research establishments, and governmental bodies is becoming increasingly prevalent in microRNA research. These collaborations harness the collective expertise, resources, and knowledge of diverse stakeholders to expedite the development and commercialization of microRNA-based products and solutions.

Increasing Utilization of MicroRNAs in Disease Biomarker Investigation: MicroRNAs exhibit considerable promise as biomarkers for various diseases, primarily owing to their stable presence in various biological fluids. Research endeavors are concentrated on the identification of distinct microRNA patterns linked to diseases, facilitating early detection, precise diagnosis, and prognostication. The growing adoption of microRNAs as disease biomarkers is propelling market expansion.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global MicroRNA Market by Research Tool
- Market Overview
- Service and product
Global MicroRNA Market by End-use
- Market Overview
- Biotechnology and pharmaceutical companies
- academic and government research institutes
- and others
Global MicroRNA Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Qiagen N.V. - Netherlands
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Thermo Fisher Scientific Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Agilent Technologies, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Illumina, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck KGaA - Germany
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- F. Hoffmann-La Roche Ltd. - Switzerland
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Rad Laboratories, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- PerkinElmer, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- System Biosciences LLC - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- New England Biolabs, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NanoString Technologies, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Exiqon A/S - Denmark
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Takara Bio Inc. - Japan
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GenScript Biotech Corporation - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eurofins Scientific SE - Luxembourg
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novartis AG - Switzerland
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Techne Corporation - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Agios Pharmaceuticals, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abcam plc - United Kingdom
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Promega Corporation - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments